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Background/aim: Lycopene, which is suggested to be a potent antioxidant, may play a protective role in diseases related to oxidative
stress. In order to understand the effects of lycopene in the pathogenesis of cholestasis, we investigated the effects of lycopene on
oxidative stress parameters and DNA damage induced by experimental biliary obstruction in the liver tissues and the lymphocytes of
Wistar albino rats.
Materials and methods: The animals were randomized into 3 groups. The sham group was subjected to a sham operation, the BDL
group was subjected to bile duct ligation (BDL), and the BDL+L group was subjected to BDL and treated with 10 mg/kg body weight of
lycopene. After 7 days of treatment, the liver functions, oxidative stress parameters, and DNA damage were evaluated.
Results: The lycopene treatment significantly ameliorated the liver function parameters in BDL rats. It significantly reduced
malondialdehyde and nitric oxide levels and enhanced reduced glutathione levels and catalase, superoxide dismutase, and glutathione S
transferase activities in the BDL rats. The lycopene treatment also decreased DNA damage as assessed by comet assay in the lymphocytes
and hepatocytes of the BDL rats.
Conclusion: These results suggest that lycopene might have protective effects on acute cholestasis.
Key words: Lycopene, cholestasis, DNA damage, oxidative stress, peripheral lymphocytes, liver

1. Introduction
Many clinical conditions, including strictures of the bile
duct, gallstone complications of pancreatitis, or biliary
surgery, are cited among etiologies that lead to a decrease
in biliary flow, causing cholestasis (1). Cholestasis leads to
acute hepatic injury and results in progressive fibrosis (2).
The production of free oxygen radicals has been suggested
to play an important role in the pathogenesis of cholestasis.
One of the significant endpoints leading to liver damage
arising from cholestasis is considered to be intrahepatic
accumulation of toxic bile salts and inflammatory cells (3).
A validated experimental model of acute cholestasis in rats
can be presented by bile duct ligation (BDL) (4).
Lipid peroxidation may result from the excessive
production of reactive oxygen species (ROS), which may
* Correspondence: drtokac@gmail.com

then interrupt the integrity of the cellular membranes
and cause further hepatic injury in cholestasis (5–7).
In cholestasis, the decline in the activity of glutathione
peroxidase (GSH-Px), as well as the decline in reduced
glutathione (GSH), may damage the antioxidant defense
system (7). Altered gene expression and DNA base damage
are the results of ROS; these may lead to the development
of cancer and mutation (8).
Useful effects of antioxidants in cholestasis have been
reported in several experimental models (9). Being a
natural antioxidant carotenoid, lycopene is suggested to
be one of the most powerful antioxidants (10). Animal
studies have indicated a large margin of safety for
lycopene. An oral 90-day toxicity study in Wistar albino
rats demonstrated the daily NOAEL of lycopene to be 586
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mg/kg body weight for males and 616 mg/kg body weight
for females (11).
In many studies, lycopene’s possible protective role
against some oxidative stress-related organ toxicities and
diseases through the protecting of biomolecules such as
DNA, proteins, and lipids has been reported (10,12–14).
In addition to the antioxidant activity of lycopene, other
possible mechanisms, such as the activation of the immune
system and metabolic pathways and the modulation of gap
junction communication, can also play important roles in
its protective activity (15).
In our previous study, we identified changes in the
oxidative stress parameters and DNA damage in the
peripheral lymphocytes, the whole blood cells, and the
liver and kidney tissues of rats given a daily dose of 100
mg/kg lycopene for 14 days in an experimental obstructive
jaundice model (16). In this study, we aimed to evaluate
the protective effects of a 7-day treatment of 10 mg/kg
lycopene on oxidative stress and DNA damage in the
lymphocytes and the liver cells of bile duct-ligated Wistar
albino rats.
2. Material and methods
2.1. Animals and experimental design
A total of 24 healthy adult male Wistar albino rats (Rattus
norvegicus) weighing 200–250 g, housed in stainless steel
cages under a controlled temperature (22 °C) and humidity
(55%–60%) and with a 12-h light/dark cycle, were used in
this study. Standard laboratory rat feed containing 21%
protein and fresh drinking water were given ad libitum
before and after the operation. The animals were treated
humanely with regard to alleviation of suffering, and
the study protocol was designed according to the ethical
standards for animal use and approved by the Ankara
Education and Research Hospital Ethics Committee of
Animal Use (25-29/01/2011).
All surgical procedures were performed under
anesthesia by intraperitoneal injection of 80 mg/kg
ketamine hydrochloride (Ketalar, İstanbul, Turkey), plus
10 mg/kg xylazine. A midline incision was made under
sterile techniques. After a midline laparotomy of 1–2 cm,
the common bile duct was identified, doubly ligated using
5-0 silk sutures, and transected at the level 0.7–0.8 cm
distal to the last bifurcation (17).
The animals were randomized into 3 groups with
8 in each group. The sham group was subjected to a
sham operation and treated with 0.5 mL of maize oil
intragastrically (i.g.) once daily. The BDL group was
subjected to BDL and was treated with 0.5 mL of maize
oil i.g. once daily. The BDL+L group was subjected to
BDL and was treated with a suspension of 10 mg/kg body
weight of lycopene (Sigma, St. Louis, MO, USA) in 0.5 mL
of maize oil i.g. once daily, as described in a previous study
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(18). All treatments started 3 days before the operation
and continued 7 days after the operation.
Blood samples via cardiac puncture were collected in
preservative-free heparin tubes for biochemical evaluation
and DNA damage analysis. The heparinized blood samples
were kept in the dark at 4 °C and were processed within
6 h. The liver tissues were carefully dissected from their
attachments and were totally excised. Excised tissues were
divided into 3 parts for histopathological examination,
DNA damage analysis, and determination of antioxidant
parameters.
2.2. Biochemical analyses
Plasma from heparinized blood samples was examined
for direct bilirubin (D-Bil), aspartate aminotransferase
(AST), alanine aminotransferase (ALT), gamma glutamyl
transferase (GGT), and alkaline phosphatase (AP) using
spectrophotometric analysis as the indicator of the
hepatic functions with standard diagnostic kits (Roche
Diagnostics, Mannheim, Germany) and a Roche modular
P800 clinical chemistry analyzer.
2.3. Determination of oxidative stress parameters in the
liver tissues
The liver tissue was extracted following a homogenization
and sonication procedure (19). The levels of
malondialdehyde (MDA), GSH, nitric oxide (NO),
superoxide dismutase (SOD), catalase (CAT), and
glutathione-S-transferase (GST) in the liver tissue
homogenates were analyzed.
MDA levels, as a biomarker of lipid peroxidation,
were determined spectrophotometrically by measuring
thiobarbituric acid-reactive substances (TBARS). The
results were expressed as pmol/mg protein.
GSH levels were determined spectrophotometrically
with a GSH assay kit (Cayman Chemicals Co., Ann Arbor,
MI, USA) at 405 nm according to the manufacturer’s
instructions. NO levels were determined using a nitrate/
nitrite colorimetric assay kit (Cayman Chemicals Co.)
at 550 nm according to the manufacturer’s instructions.
Results were expressed as nmol/mg tissue.
The determination of tissue CAT, SOD, and GST level
activities was performed with a CAT colorimetric assay kit
(Sigma-Aldrich, St Louis, MO, USA) at 520 nm, a SOD
assay kit (Cayman Chemicals Co.) at 440 nm, and GST
assay kit (Cayman Chemicals Co.) at 340 nm, respectively,
according to the manufacturer’s instructions. Results were
expressed as U/mg protein.
Protein concentrations of the tissue homogenates were
determined using the method described by Lowry et al.
(20).
2.4. Determination of DNA damage
Single-cell gel electrophoresis (comet assay) was employed
to assess the DNA damage. We followed the fundamental
alkaline technique of Singh et al. (21), which was further
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described by Anderson et al. (22) and Collins et al. (23).
The separation of lymphocytes from the whole heparinized
blood was done using the Ficoll-Hypaque density gradient
and centrifugation (24). Afterwards, the cells were washed
using PBS buffer. We put a small piece of liver tissue into
1 mL of cold Hanks Balanced Salt Solution (HBSS) with
20 mM EDTA/10% DMSO, and then we cut the tissue
into tiny pieces. The pieces were allowed to settle, and
the supernatant containing the single-cell suspension
was taken. The concentrations of lymphocytes and the
hepatocytes using PBS buffer were adjusted to around 2 ×
106 cells/mL. The cells were inserted into agarose gel and,
in order to form a comet, were lysed. Fragmented DNA
strands were pulled out using electrophoresis (alkaline
conditions). The details of comet assay protocol were
published previously (16).
2.5. Histopathological evaluation
Excised tissue specimens were fixed in 10% formalin
processed in graded alcohol and xylene and were then
embedded in paraffin. The sections were stained with
hematoxylin and eosin (H&E) and Masson’s trichrome
according to the standard procedure for routine
histopathological examination under a light microscope
(Olympus BX51, Hamburg, Germany). The histological
examination was performed by an experienced histologist
who was uninformed about of the treatment groups.
Portal inflammation, focal necrosis, and ductal
proliferation were examined according to the modified
histological activity index score proposed by Knodell et al.
(25).
2.6. Statistical analysis
Statistical analysis was performed with SPSS 15.0 for
Windows. The differences between the means of data were
compared by one-way variance analysis (ANOVA) test and
post hoc analysis of group differences was performed by
least significant difference (LSD) test. The Kruskal–Wallis
H test was used in comparing parameters displaying
abnormal distribution between groups. The results were

given as the mean ± standard deviation, and P < 0.05 was
considered as statistically significant.
3. Results
3.1. Chemical findings
The plasma biochemical parameters as markers of
hepatocellular damage are shown in Table 1. D-Bil, AST,
ALT, GGT, and AP levels were found to be significantly
higher in the BDL group (P < 0.001) and the lycopenetreated BDL group (P < 0.001) compared to the sham
group. However, these parameters in the BDL+L group
were found to be significantly lower than in the BDL group
(P < 0.001).
3.2. Oxidative stress parameters in the liver tissues
Hepatic MDA and NO levels were found to increase
significantly in the BDL group compared to the sham
group (P < 0.001) (Table 2). These levels were found to
be significantly decreased in the BDL+L group compared
to the BDL group (P < 0.001) (Table 2). There was no
significant difference between the sham group and the
BDL+L group (P = 0.786 for MDA levels; P = 0.812 for NO
levels) (Table 2).
GSH levels were found to decrease significantly in
the BDL group compared to the sham group (P = 0.008).
These levels were found to be significantly increased in
the BDL+L group compared to the BDL group (P = 0.012)
(Table 2). There was no significant difference between the
sham group and the BDL+L group (P = 0.681).
The levels of hepatic CAT, SOD, and GST were found
to decrease significantly in the BDL group compared to the
sham group (P < 0.001) (Table 2). These levels were found
to be significantly lower in the BDL group than the BDL+L
group (P < 0.001 for CAT and SOD levels; P = 0.011 for
GST levels) (Table 2). However, there was no significant
difference in these enzyme levels between the sham and
the BDL+L groups (P = 0.641 for CAT level; P = 0.875 for
SOD levels; P = 0.750 for GST levels) (Table 2).

Table 1. Plasma biochemical measurements.
Sham group

BDL group

BDL+L group

D-Bil (mg/dL)

0.07 ± 0.03 a

15.1 ± 4.2 b

7.5 ± 1.5 c

AST (U/L)

114.0 ± 3.9 a

672.0 ± 102.8 b

319.7 ± 141.8 c

ALT (U/L)

64.4 ± 18.1 a

276.7 ± 68.3 b

142.7 ± 42.6 c

GGT (U/L)

3.3 ± 3.1 a

80.6 ± 13.5 b

26.4 ± 15.3 c

AP (U/L)

341.2 ± 66.9 a

772.0 ± 107.5 b

582.0 ± 74.1 c

The results are given as the mean ± standard deviation for 8 rats in each group. Values with superscripts of
different letters differ significantly (P < 0.05) from each other within the same row.
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Table 2. Hepatic MDA, GSH, NO, CAT, SOD, and GST levels.
Sham group

BDL group

MDA (pmol/mg protein)

73.2 ± 10.9

107.2 ± 14.9

GSH (nmol/mg tissue

3.0 ± 1.3 a

0.9 ± 0.9 b

2.4 ± 1.0 a

NO (nmol/mg tissue)

68.0 ± 8.9 a

113.8 ± 17.5 b

73.2 ± 3.6 a

CAT (U/mg protein)

135.0 ± 21.4 a

69.8 ± 7.5 b

116.6 ± 9.2 a

SOD (U/mg protein)

76.0 ± 12.3 a

35.4 ± 6.6 b

71.5 ± 11.0 a

GST (U/mg protein)

0.5 ± 0.1 a

0.2 ± 0.1 b

0.4 ± 0.1 a

a

BDL+L group
64.5 ± 16.9 a

b

The results are given as the mean ± standard deviation for 8 rats in each group. Values with superscripts of
different letters differ significantly (P < 0.05) from each other within the same row.

3.4. Histopathological findings
The histological structure of the liver was observed to
be normal in the sham group, as seen in Figure 2A and
Figure 2B. There was edema and widening of the portal
tracts due to extensive bile ductal proliferation (Figure
2C). Inflammatory infiltration, including neutrophil
leukocytes, in the portal tracts was also prominent in
the BDL group (Figure 2C). Focal necrosis was observed
in the BDL group (Figure 2D). Portal inflammation and

3.3. Assessment of DNA damage
BDL seemed to induce DNA damage in the lymphocytes
and the hepatocytes because all the parameters studied
were found to increase in the BDL group compared to
the sham group (P < 0.001) (Figure 1). Lycopene seemed
to significantly reduce the DNA damage, since all of the
parameters studied in all samples were found to decrease
significantly in the BDL+L group when compared to the
BDL group (P < 0.001).
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Figure 1. The effects of lycopene on cholestasis-induced DNA damage in the lymphocytes and hepatocytes of rats.
DNA damage was expressed as DNA tail length, DNA tail intensity, and DNA tail moment in the lymphocytes (A)
and the hepatocytes (B) of the experimental groups. Results were given as the mean ± standard deviation for 8 rats
in each group. Values with superscripts of different letters differ significantly (P < 0.05).
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Figure 2. Histopathologic section of hepatic tissue. A) Normal liver histology from the sham group (H&E, ×100 µm); B) a portal
tract from the sham group (H&E, ×20 µm); C) portal inflammation including neutrophil leukocytes and bile ductal proliferation in
the BDL group (H&E, ×20 µm); D) a necrotic focus near the portal tract in the BDL group (H&E, ×20 µm); E) portal inflammation
and bile ductal proliferations (arrowhead) in the BDL+L group (H&E, ×50 µm).

ductal proliferation were markedly attenuated in the
BDL+L group compared to the BDL group (Figure 2E).
The frequency of necrotic focus seemed to be reduced in
the BDL+ L group compared to the BDL group (Figure
2C and Figure 2E). The number of inflammatory cells in
the portal areas and leukocyte permeation of the bile duct
epithelium also seemed to decrease in the BDL+L group
compared to the BDL group (Figure 2E).
The mean grades of liver portal inflammation were
found to be 0.29 ± 0.49, 1.86 ± 0.38, and 0.71 ± 0.45 in
the sham, BDL, and BDL+L groups, respectively. Liver
portal inflammation was found to increase significantly
in the BDL group compared to the sham group (P <
0.001). Lycopene treatment seemed to reduce liver
portal inflammation significantly in the BDL+L group
compared to the BDL group (P = 0.016). However, portal
inflammation was found to increase in the BDL+L group
compared to the sham group (P < 0.035) (Table 3).
The mean grades of liver lobular inflammation were
found to be 0.57 ± 0.53, 1.71 ± 0.49, and 1.14 ± 0.64 in
the sham, BDL, and BDL+L groups, respectively. The liver
lobular inflammation was found to increase significantly
in the BDL group (P < 0.001) and the BDL+L group (P =
0.027) compared to the sham group. However, lycopene

treatment did not significantly reduce the liver lobular
inflammation in the BDL+L group compared to the BDL
group (P = 0.561) (Table 3).
The mean grades of ductal proliferation in the portal
area were found to be 0.43 ± 0.53, 2.86 ± 0.90, and 1.86 ±
0.83 in the sham, BDL, and BDL+L groups, respectively.
It was found that bile ductal proliferation in the portal
area increased significantly in the BDL group (P < 0.001)
and the BDL+L group (P = 0.009) compared to the sham
group. Bile ductal proliferation was found to decrease
significantly in the BDL+L group compared to the BDL
group (P = 0.034) (Table 3).
4. Discussion
Different biologic targets such as DNA, lipids, and proteins
may be inflicted with damage by oxygen-derived free
radicals, which are highly reactive intermediates (26).
Tissue injury may occur because of the free radicals
that cause lipid peroxidation, and accumulation of lipid
peroxidation products in human tissues is cited among the
major reasons behind tissue dysfunction (27). Nevertheless,
tissues are equipped with a range of defense mechanisms,
and scavenger antioxidant molecules can provide protection
against the damage caused by free radicals (28).
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Table 3. Evaluation of portal inflammation, lobular inflammation, and bile ductal proliferation in the liver tissues of rats.
Sham group

BDL group
1.86 ± 0.38 (1–2)

BDL+L group
b

0.71 ± 0.45 (0–1) c

Liver portal inflammation

0.29 ± 0.49 (0–1)

Liver lobular inflammation

0.57 ± 0.53 (0–1) a

1.71 ± 0.49 (1–2) b

1.14 ± 0.64 (0–2) b

Bile ductal proliferation

0.43 ± 0.53 (0–1) a

2.86 ± 0.90 (2–4) b

1.86 ± 0.83 (1–3) c

a

The results are given as the mean ± standard deviation (min–max) for 8 rats in each group. Values with superscripts of
different letters differ significantly (P < 0.05) from each other within the same row.

An increase in bilirubin fractions and hepatic plasma
enzymes leads to the significant assumption that cholestasis
raises hepatic oxidative stress. These increases in bilirubin
fractions and hepatic plasma enzymes are symptoms of
cholestasis, hepatic dysfunction, and liver injury (29,30).
In our study, AP, AST, GGT, D-Bil, and ALT levels
indicating hepatic functions tended to increase remarkably
in cholestasis, providing evidence that liver functions were
affected by cholestasis. Daily administration of lycopene
(25 mg kg–1 day–1) for 14 days before the experiments
notably decreased the liver injury markers (GGT, ALT,
AST, and lactate dehydrogenase) caused by ischemia
reperfusion injury in rats (30). It was also reported that 40
mg/kg lycopene decreased ALT levels in rats treated with
mercuric chloride (31). In our study, we also found that
lycopene treatment (10 mg kg–1 day–1 for 7 days) reduced
the plasma hepatocellular damage parameters (D-Bil, AST,
ALT, GGT, and AP) in rats with cholestasis.
MDA, which is an outcome of the lipid peroxidation
process, is accumulated in tissues. This serves as an
indication of the scale of oxidative stress and lipid
peroxidation. Damage to important cellular components
resulting from free radicals and peroxides can be prevented
by GSH, which is an endogenous antioxidant (32). A rise
in hepatic, systemic, and renal MDA formation has been
linked to cholestasis. Orellana et al. (33) reported that
cholestasis-induced rats had increased GSH and MDA
levels in liver tissues, which demonstrated the production
of oxidative stress by cholestasis. In our study, we found
a decline in GSH levels and a rise in MDA levels in the
liver tissue in the bile duct ligated rats, and that finding
is in line with the study of Gonzalez-Correa et al. (29)
determining the effects of S-adenosyl-L-methionine on
hepatic oxidative stress using a model of extrahepatic
biliary obstruction of 7 days’ duration .
Our study showed that MDA levels were decreased
while GSH levels were increased in the liver tissue of BDL
rats because of the 7-day lycopene treatment. One earlier
study, being in line with our findings, showed a remarkable
decline in retinol, lycopene, alpha- and beta-carotene, total
carotenoid, and lutein levels in cholestatic liver diseases
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such as sclerosing cholangitis and primary biliary cirrhosis
compared to the control groups (34). It was reported that
a 14-day administration of lycopene (25 mg kg–1 day–1)
decreased the liver MDA levels in rats with the ischemia
reperfusion injury (30). Similarly, Deng et al. (31) reported
that 40 mg/kg lycopene administered once a day for 2 days
notably decreased the liver MDA levels in rats in mercury
chloride-induced hepatotoxicity conditions.
The intestinal mucosal barrier in cholestasis is
disturbed by high-level biliary salts, which then cause the
transfer of enteric bacteria to the mesenteric lymph nodes
and liver. This results in endotoxemia, which is the reason
behind increased NO synthesis by inducible NO synthase
(35). Both in patients with primary biliary cirrhosis and in
experimental cholestasis (5,35), the overproduction of NO
was found (35). Among causes of the rapid development
of hepatic dysfunction in cholestasis and hepatocellular
injury, there is the rise in plasma and hepatic levels of
NO and cytokines. We observed that NO level increased
in the liver tissue of rats with cholestasis, while indicating
that the lycopene treatment contributed to the decrease in
BDL-induced NO level.
It is noteworthy to mention the crucial function
of antioxidant enzymes such as CAT, SOD, and GST
in cellular defense against free radicals. Oxidative
stress in cholestasis also damages the liver antioxidant
system (36). It was found that the livers of BDL rats had
decreased levels of GST, SOD, CAT, GSH, and GSH-Px
(37). It was also reported in some types of chemicalinduced damage that antioxidant enzyme levels such as
GGT, SOD, CAT, and GSH-Px were increased (38). In
our study, levels of antioxidant enzymes such as GST,
SOD, and CAT in the liver tissue were decreased in
cholestasis. This could be interpreted as an indication of
oxidative imbalance of the tissue. We observed that the
increases in GST, SOD, and CAT levels in the liver tissues
of BDL rats were provided with lycopene treatment. This
shows that lycopene might have a significant activity
in maintaining antioxidant enzymes. Our findings are
in accordance with recent studies indicating the useful
effects of lycopene (14,16,18).
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Oxidative DNA damage can be notably reduced
by the ingestion of certain vegetables or fruits. It was
observed that lycopene had preventive effect against
oxidative damage to cell membranes and DNA, and that it
remarkably alleviated histological changes caused by free
radicals in the rat liver and in many cells (39,40). To assess
whether consumption of vegetables containing different
carotenoids might protect against DNA damage and
oxidative DNA damage in 23 healthy, nonsmoking males
aged 27–40, Pool-Zobel et al. (41) found that a 2-week-long
supplementation with tomato juice (40 mg/day lycopene),
carrot juice (22.3 mg/day beta-carotene and 15.7 mg/day
alpha-carotene), or 10 g of spinach powder (11.3 mg/day
lutein) resulted in significantly decreased DNA strand
breaks in the lymphocytes (41). The findings of Zhao et
al. (42) indicated a reduction in endogenous DNA damage
following a 57-day intake of supplements such as betacarotene, lycopene, and lutein and a combination of all
three. Our study, on the other hand, found increased DNA
damage in the lymphocytes and liver tissue cells in BDL
rats. However, DNA damage caused by cholestasis was
prevented by lycopene, thus confirming earlier studies
(40–42).
Toxic bile salt accumulation in the liver tissue may be
one of the causes of increased free radical production in
cholestasis. It is considered to be one of the significant
causes in the development of liver damage resulting
from cholestasis. Kisseleva and Brenner (43) reported
that a radical increase in liver and serum bile acid levels

resulted in the proliferation of bile ducts, liver toxicity,
and fibrosis, which develop into cirrhosis. Dirlik et al.
(7) also found that following common BDL, the ductal
proliferation grows increasingly, and it reaches the
top level after 5 days in rats. Cholestatic liver disease
appears with hepatic inflammation, which is one of its
significant traits; proliferation of the biliary epithelial cells,
portal tract fibrosis, portal tract edema, and neutrophil
infiltration in the portal tracts are among the inflammatory
characteristics of obstructive cholestasis (44). In this study,
we found that in the rats with cholestasis, focal necrosis,
liver portal inflammation, and bile ductal proliferation
advanced after 7 days, indicating that cholestasis furthered
the liver tissue damage.
To conclude, we indicated the significant role of
oxidative stress in the development of cholestasis. We
further showed the protective effect of lycopene in
cholestasis, noting that lycopene is among the most potent
chemicals to prevent free radicals. Lycopene treatment
may be a useful tool to reduce tissue injury associated
with cholestasis-induced oxidative stress. Therefore, it
is obvious that this can pave the way for possible useful
effects of the use of lycopene to combat patient disorders
associated with cholestasis in the clinic and during followup. However, there is still a need to shed light on the in
vivo mechanisms of lycopene and for further study with
the intention of exploring the effectiveness of lycopene
on other organs, in addition to the liver, in the course of
cholestasis.
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